 | • レポートコード：QAF20564 • 出版社/出版日：QYResearch / 2021年4月6日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：化学＆材料 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の医薬品有効成分（API）市場について種類別（合成API、バイオテクノロジーAPI）、用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・医薬品有効成分（API）市場の概要 ・世界の主要地域別医薬品有効成分（API）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の医薬品有効成分（API）市場規模2016-2021：種類別（合成API、バイオテクノロジーAPI） ・世界の医薬品有効成分（API）市場予測2012-2027：種類別（合成API、バイオテクノロジーAPI） ・世界の医薬品有効成分（API）市場規模2016-2021：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他） ・世界の医薬品有効成分（API）市場予測2012-2027：用途別（CNS、循環器、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他） ・医薬品有効成分（API）のアメリカ市場規模と予測2016-2021 ・医薬品有効成分（API）のヨーロッパ市場規模と予測2016-2021 ・医薬品有効成分（API）の中国市場規模と予測2016-2021 ・医薬品有効成分（API）の日本市場規模と予測2016-2021 ・医薬品有効成分（API）の東南アジア市場規模と予測2016-2021 ・医薬品有効成分（API）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Mylan、DSM、Aurobindo Pharma、Aspen、Novartis、BASF、Pfizer、Huahai Pharmaceutical、Hisun Pharmaceutical、Sun Pharmaceutical Industries、Zhejiang Medicine、Dr. Reddy’s Laboratories、Zhejiang NHU、Bayer、NCPC、AbbVie、Shandong Xinhua Pharmaceutical、Northeast Pharm、Harbin Pharmaceutical、LKPC） ・医薬品有効成分（API）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・医薬品有効成分（API）の市場動向・機会・課題 ・調査の結論 |
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market
The global Active Pharmaceutical Ingredients (API) market was valued at US$ 72090 in 2020 and will reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2022-2027.
Global Active Pharmaceutical Ingredients (API) Scope and Market Size
The global Active Pharmaceutical Ingredients (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
The Active Pharmaceutical Ingredients (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Active Pharmaceutical Ingredients (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Active Pharmaceutical Ingredients (API) Product Scope
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Sales by Type (2016 & 2021 & 2027)
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Active Pharmaceutical Ingredients (API) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Active Pharmaceutical Ingredients (API) Price Trends (2016-2027)
2 Active Pharmaceutical Ingredients (API) Estimates and Forecasts by Region
2.1 Global Active Pharmaceutical Ingredients (API) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Active Pharmaceutical Ingredients (API) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
2.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
2.3 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
2.4.2 Europe Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
2.4.3 China Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
2.4.4 Japan Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
2.4.6 India Active Pharmaceutical Ingredients (API) Estimates and Projections (2016-2027)
3 Global Active Pharmaceutical Ingredients (API) Competition Landscape by Players
3.1 Global Top Active Pharmaceutical Ingredients (API) Players by Sales (2016-2021)
3.2 Global Top Active Pharmaceutical Ingredients (API) Players by Revenue (2016-2021)
3.3 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2020)
3.4 Global Active Pharmaceutical Ingredients (API) Average Price by Company (2016-2021)
3.5 Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Active Pharmaceutical Ingredients (API) Market Size by Type
4.1 Global Active Pharmaceutical Ingredients (API) Historic Market Review by Type (2016-2021)
4.1.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
4.1.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2021)
4.2 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Type (2022-2027)
4.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2022-2027)
4.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2022-2027)
5 Global Active Pharmaceutical Ingredients (API) Market Size by Application
5.1 Global Active Pharmaceutical Ingredients (API) Historic Market Review by Application (2016-2021)
5.1.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
5.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2021)
5.1.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2016-2021)
5.2 Global Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Active Pharmaceutical Ingredients (API) Sales Forecast by Application (2022-2027)
5.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Application (2022-2027)
5.2.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2022-2027)
6 North America Active Pharmaceutical Ingredients (API) Market Facts & Figures
6.1 North America Active Pharmaceutical Ingredients (API) Sales by Company
6.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
6.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
6.2 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
6.2.1 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
6.2.2 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
6.3 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
6.3.1 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2016-2021)
6.3.2 North America Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2022-2027)
7 Europe Active Pharmaceutical Ingredients (API) Market Facts & Figures
7.1 Europe Active Pharmaceutical Ingredients (API) Sales by Company
7.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
7.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
7.2 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
7.2.1 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
7.3 Europe Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Active Pharmaceutical Ingredients (API) Market Facts & Figures
8.1 China Active Pharmaceutical Ingredients (API) Sales by Company
8.1.1 China Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
8.1.2 China Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
8.2 China Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
8.2.1 China Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
8.2.2 China Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
8.3 China Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan Active Pharmaceutical Ingredients (API) Market Facts & Figures
9.1 Japan Active Pharmaceutical Ingredients (API) Sales by Company
9.1.1 Japan Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
9.1.2 Japan Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
9.2 Japan Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
9.2.1 Japan Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
9.3 Japan Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Active Pharmaceutical Ingredients (API) Market Facts & Figures
10.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Company
10.1.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
10.1.2 Southeast Asia Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
10.2 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
10.2.1 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Active Pharmaceutical Ingredients (API) Market Facts & Figures
11.1 India Active Pharmaceutical Ingredients (API) Sales by Company
11.1.1 India Active Pharmaceutical Ingredients (API) Sales by Company (2016-2021)
11.1.2 India Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021)
11.2 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Type
11.2.1 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2016-2021)
11.2.2 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Type (2022-2027)
11.3 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Application
11.3.1 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2016-2021)
11.3.2 India Active Pharmaceutical Ingredients (API) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Active Pharmaceutical Ingredients (API) Products Offered
12.1.5 Teva Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Active Pharmaceutical Ingredients (API) Products Offered
12.2.5 Mylan Recent Development
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Business Overview
12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 DSM Active Pharmaceutical Ingredients (API) Products Offered
12.3.5 DSM Recent Development
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Business Overview
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Products Offered
12.4.5 Aurobindo Pharma Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Business Overview
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Active Pharmaceutical Ingredients (API) Products Offered
12.5.5 Aspen Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Active Pharmaceutical Ingredients (API) Products Offered
12.6.5 Novartis Recent Development
12.7 BASF
12.7.1 BASF Corporation Information
12.7.2 BASF Business Overview
12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 BASF Active Pharmaceutical Ingredients (API) Products Offered
12.7.5 BASF Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Products Offered
12.8.5 Pfizer Recent Development
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Corporation Information
12.9.2 Huahai Pharmaceutical Business Overview
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.9.5 Huahai Pharmaceutical Recent Development
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Corporation Information
12.10.2 Hisun Pharmaceutical Business Overview
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.10.5 Hisun Pharmaceutical Recent Development
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Corporation Information
12.11.2 Sun Pharmaceutical Industries Business Overview
12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Products Offered
12.11.5 Sun Pharmaceutical Industries Recent Development
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Corporation Information
12.12.2 Zhejiang Medicine Business Overview
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Products Offered
12.12.5 Zhejiang Medicine Recent Development
12.13 Dr. Reddy’s Laboratories
12.13.1 Dr. Reddy’s Laboratories Corporation Information
12.13.2 Dr. Reddy’s Laboratories Business Overview
12.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Products Offered
12.13.5 Dr. Reddy’s Laboratories Recent Development
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Corporation Information
12.14.2 Zhejiang NHU Business Overview
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Products Offered
12.14.5 Zhejiang NHU Recent Development
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Business Overview
12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Bayer Active Pharmaceutical Ingredients (API) Products Offered
12.15.5 Bayer Recent Development
12.16 NCPC
12.16.1 NCPC Corporation Information
12.16.2 NCPC Business Overview
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 NCPC Active Pharmaceutical Ingredients (API) Products Offered
12.16.5 NCPC Recent Development
12.17 AbbVie
12.17.1 AbbVie Corporation Information
12.17.2 AbbVie Business Overview
12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 AbbVie Active Pharmaceutical Ingredients (API) Products Offered
12.17.5 AbbVie Recent Development
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
12.18.2 Shandong Xinhua Pharmaceutical Business Overview
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.18.5 Shandong Xinhua Pharmaceutical Recent Development
12.19 Northeast Pharm
12.19.1 Northeast Pharm Corporation Information
12.19.2 Northeast Pharm Business Overview
12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Products Offered
12.19.5 Northeast Pharm Recent Development
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Corporation Information
12.20.2 Harbin Pharmaceutical Business Overview
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Products Offered
12.20.5 Harbin Pharmaceutical Recent Development
12.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Business Overview
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2016-2021)
12.21.4 LKPC Active Pharmaceutical Ingredients (API) Products Offered
12.21.5 LKPC Recent Development
13 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
13.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
13.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Active Pharmaceutical Ingredients (API) Distributors List
14.3 Active Pharmaceutical Ingredients (API) Customers
15 Market Dynamics
15.1 Active Pharmaceutical Ingredients (API) Market Trends
15.2 Active Pharmaceutical Ingredients (API) Drivers
15.3 Active Pharmaceutical Ingredients (API) Market Challenges
15.4 Active Pharmaceutical Ingredients (API) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Active Pharmaceutical Ingredients (API) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Active Pharmaceutical Ingredients (API) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Active Pharmaceutical Ingredients (API) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Region (2016-2021)
Table 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Table 6. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue Share by Region (2016-2021)
Table 8. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Active Pharmaceutical Ingredients (API) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Active Pharmaceutical Ingredients (API) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Active Pharmaceutical Ingredients (API) Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Active Pharmaceutical Ingredients (API) Sales Share by Company (2016-2021)
Table 14. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Active Pharmaceutical Ingredients (API) Revenue Share by Company (2016-2021)
Table 16. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2020)
Table 17. Global Active Pharmaceutical Ingredients (API) Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Active Pharmaceutical Ingredients (API) Manufacturing Sites and Area Served
Table 19. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Type (2016-2021)
Table 22. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2016-2021)
Table 23. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Type (2016-2021)
Table 25. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2022-2027)
Table 26. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2022-2027)
Table 28. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Type (2022-2027)
Table 29. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2016-2021)
Table 30. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2016-2021)
Table 31. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Application (2016-2021)
Table 33. Global Active Pharmaceutical Ingredients (API) Sales (K MT) by Application (2022-2027)
Table 34. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2022-2027)
Table 35. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2022-2027)
Table 37. Global Active Pharmaceutical Ingredients (API) Price (USD/MT) by Application (2022-2027)
Table 38. North America Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 39. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 40. North America Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 42. North America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 43. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 44. North America Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 45. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 46. North America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 47. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 48. North America Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 49. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 50. Europe Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 51. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 52. Europe Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 54. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 55. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 56. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 57. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 58. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 59. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 60. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 61. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 62. China Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 63. China Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 64. China Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 66. China Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 67. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 68. China Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 69. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 70. China Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 71. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 72. China Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 73. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 74. Japan Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 75. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 76. Japan Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 78. Japan Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 79. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 80. Japan Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 81. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 82. Japan Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 83. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 84. Japan Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 85. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 98. India Active Pharmaceutical Ingredients (API) Sales (K MT) by Company (2016-2021)
Table 99. India Active Pharmaceutical Ingredients (API) Sales Market Share by Company (2016-2021)
Table 100. India Active Pharmaceutical Ingredients (API) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Active Pharmaceutical Ingredients (API) Revenue Market Share by Company (2016-2021)
Table 102. India Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 103. India Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2021)
Table 104. India Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 105. India Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2022-2027)
Table 106. India Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 107. India Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2021)
Table 108. India Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 109. India Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Teva Active Pharmaceutical Ingredients (API) Product
Table 114. Teva Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Mylan Active Pharmaceutical Ingredients (API) Product
Table 119. Mylan Recent Development
Table 120. DSM Corporation Information
Table 121. DSM Description and Business Overview
Table 122. DSM Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. DSM Active Pharmaceutical Ingredients (API) Product
Table 124. DSM Recent Development
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product
Table 129. Aurobindo Pharma Recent Development
Table 130. Aspen Corporation Information
Table 131. Aspen Description and Business Overview
Table 132. Aspen Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Aspen Active Pharmaceutical Ingredients (API) Product
Table 134. Aspen Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Novartis Active Pharmaceutical Ingredients (API) Product
Table 139. Novartis Recent Development
Table 140. BASF Corporation Information
Table 141. BASF Description and Business Overview
Table 142. BASF Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. BASF Active Pharmaceutical Ingredients (API) Product
Table 144. BASF Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Pfizer Description and Business Overview
Table 148. Pfizer Active Pharmaceutical Ingredients (API) Product
Table 149. Pfizer Recent Development
Table 150. Huahai Pharmaceutical Corporation Information
Table 151. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Huahai Pharmaceutical Description and Business Overview
Table 153. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 154. Huahai Pharmaceutical Recent Development
Table 155. Hisun Pharmaceutical Corporation Information
Table 156. Hisun Pharmaceutical Description and Business Overview
Table 157. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 159. Hisun Pharmaceutical Recent Development
Table 160. Sun Pharmaceutical Industries Corporation Information
Table 161. Sun Pharmaceutical Industries Description and Business Overview
Table 162. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product
Table 164. Sun Pharmaceutical Industries Recent Development
Table 165. Zhejiang Medicine Corporation Information
Table 166. Zhejiang Medicine Description and Business Overview
Table 167. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product
Table 169. Zhejiang Medicine Recent Development
Table 170. Dr. Reddy’s Laboratories Corporation Information
Table 171. Dr. Reddy’s Laboratories Description and Business Overview
Table 172. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product
Table 174. Dr. Reddy’s Laboratories Recent Development
Table 175. Zhejiang NHU Corporation Information
Table 176. Zhejiang NHU Description and Business Overview
Table 177. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product
Table 179. Zhejiang NHU Recent Development
Table 180. Bayer Corporation Information
Table 181. Bayer Description and Business Overview
Table 182. Bayer Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Bayer Active Pharmaceutical Ingredients (API) Product
Table 184. Bayer Recent Development
Table 185. NCPC Corporation Information
Table 186. NCPC Description and Business Overview
Table 187. NCPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. NCPC Active Pharmaceutical Ingredients (API) Product
Table 189. NCPC Recent Development
Table 190. AbbVie Corporation Information
Table 191. AbbVie Description and Business Overview
Table 192. AbbVie Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. AbbVie Active Pharmaceutical Ingredients (API) Product
Table 194. AbbVie Recent Development
Table 195. Shandong Xinhua Pharmaceutical Corporation Information
Table 196. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 197. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 199. Shandong Xinhua Pharmaceutical Recent Development
Table 200. Northeast Pharm Corporation Information
Table 201. Northeast Pharm Description and Business Overview
Table 202. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Northeast Pharm Active Pharmaceutical Ingredients (API) Product
Table 204. Northeast Pharm Recent Development
Table 205. Harbin Pharmaceutical Corporation Information
Table 206. Harbin Pharmaceutical Description and Business Overview
Table 207. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 209. Harbin Pharmaceutical Recent Development
Table 210. LKPC Corporation Information
Table 211. LKPC Description and Business Overview
Table 212. LKPC Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 213. LKPC Active Pharmaceutical Ingredients (API) Product
Table 214. LKPC Recent Development
Table 215. Production Base and Market Concentration Rate of Raw Material
Table 216. Key Suppliers of Raw Materials
Table 217. Active Pharmaceutical Ingredients (API) Distributors List
Table 218. Active Pharmaceutical Ingredients (API) Customers List
Table 219. Active Pharmaceutical Ingredients (API) Market Trends
Table 220. Active Pharmaceutical Ingredients (API) Market Drivers
Table 221. Active Pharmaceutical Ingredients (API) Market Challenges
Table 222. Active Pharmaceutical Ingredients (API) Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2021 & 2027
Figure 6. CNS Examples
Figure 7. Cardiovascular Examples
Figure 8. Genitourinary/Hormonal Drugs Examples
Figure 9. Respiratory Examples
Figure 10. Rheumatology Examples
Figure 11. Diabetes Examples
Figure 12. Oncology Examples
Figure 13. Others Examples
Figure 14. Global Active Pharmaceutical Ingredients (API) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Active Pharmaceutical Ingredients (API) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Active Pharmaceutical Ingredients (API) Sales (K MT) Growth Rate (2016-2027)
Figure 17. Global Active Pharmaceutical Ingredients (API) Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Active Pharmaceutical Ingredients (API) Sales (K MT) Growth Rate (2016-2027)
Figure 22. Europe Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Active Pharmaceutical Ingredients (API) Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Active Pharmaceutical Ingredients (API) Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Active Pharmaceutical Ingredients (API) Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in Active Pharmaceutical Ingredients (API): 2016 & 2020
Figure 33. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021)
Figure 35. Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2016-2021)
Figure 37. Global Active Pharmaceutical Ingredients (API) Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 39. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 40. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 41. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 42. China Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 43. China Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 44. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 45. Japan Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 46. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 47. Southeast Asia Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 48. India Active Pharmaceutical Ingredients (API) Sales Market Share by Type in 2020
Figure 49. India Active Pharmaceutical Ingredients (API) Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
Figure 52. Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Figure 53. Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ヘパリン有効成分のグローバル市場調査 2019年 The global Heparin Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin Active Pharmaceutical Ingredients volume and value at global level, regional level and co…- 高性能医薬品有効成分(HPAPI)のグローバル市場調査 2019年 The global High Performance Active Pharmaceutical Ingredients (HPAPI) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Performance Active Pharmaceutical Ingredients (HPAPI) volume and value at g…
- ペニシリン有効成分のグローバル市場2021 Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects…
- 世界の特殊な有効成分産業調査2019-2025 Special active pharmaceutical ingredients are bioactive chemicals used as intermediate components in pharmaceutical manufacturing, such as tablets, capsules, syrups, etc.Special active pharmaceutical ingredients include steroidal API, peptide, carbohydrate API, small molecule and high efficiency API…
- 世界の特殊な有効成分産業調査2019-2025 Special active pharmaceutical ingredients are bioactive chemicals used as intermediate components in pharmaceutical manufacturing, such as tablets, capsules, syrups, etc.Special active pharmaceutical ingredients include steroidal API, peptide, carbohydrate API, small molecule and high efficiency API…